Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Medrxiv : the Preprint Server for Health Sciences|December 21, 2021
Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron NeutralizationNicole A Doria-Rose, Xiaoying Shen, Stephen D Schmidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2022
Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron VariantRajesh M Valanparambil, Jennifer Carlisle, Susanne L Linderman, et al.
The New England Journal of Medicine|September 29, 2020
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older AdultsEvan J Anderson, Nadine G Rouphael, Alicia T Widge, et al.
Science Translational Medicine|May 15, 2024
Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assaysBarbara Mühlemann, Samuel H Wilks, Lauren Baracco, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model SeraBarbara Mühlemann, Samuel H Wilks, Lauren Baracco, et al.
Science Translational Medicine|August 17, 2022
Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccinePrabhu S Arunachalam, Yupeng Feng, Usama Ashraf, et al.
Research Square|January 4, 2022
The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamstersMichael Diamond, Peter Halfmann, Tadashi Maemura, et al.
Nature|April 19, 2021
Adjuvanting a subunit COVID-19 vaccine to induce protective immunityPrabhu S Arunachalam, Alexandra C Walls, Nadia Golden, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2021
Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primatesPrabhu S Arunachalam, Alexandra C Walls, Nadia Golden, et al.
Pageof 5